SERPINB2 and lung carcinoma: According to clinical statistics, patients with uPA-positive and SerpinB2-negative lung cancers have shown poor survival rates compared to patients positive for both uPA and SerpinB2, and the co-expression of these two markers correlated with the absence of lymph node metastasis4, 6.